Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party. [electronic resource]
Producer: 19960819Description: 161-72 p. digitalISSN:- 0003-4819
- Adult
- Antiviral Agents -- adverse effects
- Biopterins -- analogs & derivatives
- CD4 Lymphocyte Count
- Double-Blind Method
- Drug Therapy, Combination
- Female
- HIV -- genetics
- HIV Core Protein p24 -- blood
- HIV Infections -- blood
- Humans
- Lamivudine
- Male
- Neopterin
- Polymerase Chain Reaction
- RNA, Viral -- blood
- Severity of Illness Index
- Time Factors
- Treatment Outcome
- Zalcitabine -- adverse effects
- Zidovudine -- adverse effects
- beta 2-Microglobulin -- metabolism
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.